The majority of the interactions which have been documented with alprazolam are with medications that modulate CYP3A4 activity. Compounds which might be inhibitors or inducers of CYP3A could well be envisioned to improve or lower plasma alprazolam concentrations, respectively. Drug products which have been researched in vivo, in conjunction with th